ArticleCancer science2007

Excision repair cross-complementation group 1 predicts progression-free and overall survival in non-small cell lung cancer patients treated with platinum-based chemotherapy.

Koichi Azuma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.